Annual EBIT:
-$26.62M+$10.28M(+27.85%)Summary
- As of today, XERS annual earnings before interest & taxes is -$26.62 million, with the most recent change of +$10.28 million (+27.85%) on December 31, 2024.
- During the last 3 years, XERS annual EBIT has risen by +$88.93 million (+76.96%).
- XERS annual EBIT is now -101.55% below its all-time high of -$13.21 million, reached on December 31, 2016.
Performance
XERS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$5.43M+$7.34M(+383.55%)Summary
- As of today, XERS quarterly earnings before interest & taxes is $5.43 million, with the most recent change of +$7.34 million (+383.55%) on June 30, 2025.
- Over the past year, XERS quarterly EBIT has increased by +$11.72 million (+186.30%).
- XERS quarterly EBIT is now at all-time high.
Performance
XERS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$5.17M+$11.72M(+69.39%)Summary
- As of today, XERS TTM earnings before interest & taxes is -$5.17 million, with the most recent change of +$11.72 million (+69.39%) on June 30, 2025.
- Over the past year, XERS TTM EBIT has increased by +$25.05 million (+82.89%).
- XERS TTM EBIT is now -11.23% below its all-time high of -$4.65 million, reached on March 31, 2017.
Performance
XERS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XERS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +27.9% | +186.3% | +82.9% |
| 3Y3 Years | +77.0% | +123.5% | +95.9% |
| 5Y5 Years | +77.6% | +124.7% | +94.6% |
XERS EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +77.0% | at high | +129.9% | at high | +95.7% |
| 5Y | 5-Year | at high | +77.6% | at high | +111.1% | at high | +96.0% |
| All-Time | All-Time | -101.5% | +77.6% | at high | +111.1% | -11.2% | +96.0% |
XERS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.43M(+383.6%) | -$5.17M(+69.4%) |
| Mar 2025 | - | -$1.92M(-173.9%) | -$16.89M(+36.5%) |
| Dec 2024 | -$26.62M(+27.9%) | $2.59M(+123.0%) | -$26.62M(+25.7%) |
| Sep 2024 | - | -$11.28M(-79.2%) | -$35.82M(-18.5%) |
| Jun 2024 | - | -$6.29M(+45.9%) | -$30.22M(+20.3%) |
| Mar 2024 | - | -$11.64M(-76.2%) | -$37.92M(-2.8%) |
| Dec 2023 | -$36.90M(+55.0%) | -$6.61M(-16.3%) | -$36.90M(+5.9%) |
| Sep 2023 | - | -$5.68M(+59.4%) | -$39.19M(+24.2%) |
| Jun 2023 | - | -$13.99M(-31.7%) | -$51.69M(+15.0%) |
| Mar 2023 | - | -$10.62M(-19.3%) | -$60.78M(+24.7%) |
| Dec 2022 | -$81.98M(+29.0%) | -$8.90M(+51.0%) | -$80.76M(+33.2%) |
| Sep 2022 | - | -$18.18M(+21.2%) | -$120.85M(+4.8%) |
| Jun 2022 | - | -$23.08M(+24.6%) | -$126.88M(+2.0%) |
| Mar 2022 | - | -$30.60M(+37.5%) | -$129.53M(-12.1%) |
| Dec 2021 | -$115.55M | -$48.99M(-102.4%) | -$115.55M(-37.9%) |
| Sep 2021 | - | -$24.21M(+5.9%) | -$83.82M(-14.4%) |
| Jun 2021 | - | -$25.72M(-54.8%) | -$73.28M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.62M(+3.7%) | -$69.53M(+13.7%) |
| Dec 2020 | -$80.59M(+32.2%) | -$17.27M(-26.3%) | -$80.59M(+15.5%) |
| Sep 2020 | - | -$13.67M(+37.8%) | -$95.33M(+14.1%) |
| Jun 2020 | - | -$21.97M(+20.7%) | -$110.99M(+9.3%) |
| Mar 2020 | - | -$27.68M(+13.5%) | -$122.35M(-2.9%) |
| Dec 2019 | -$118.88M(-106.6%) | -$32.01M(-9.1%) | -$118.88M(-11.9%) |
| Sep 2019 | - | -$29.33M(+12.0%) | -$106.23M(-16.8%) |
| Jun 2019 | - | -$33.32M(-37.6%) | -$90.93M(-29.8%) |
| Mar 2019 | - | -$24.21M(-25.0%) | -$70.03M(-21.7%) |
| Dec 2018 | -$57.53M(-116.7%) | -$19.36M(-38.0%) | -$57.53M(-21.6%) |
| Sep 2018 | - | -$14.03M(-12.9%) | -$47.32M(-15.9%) |
| Jun 2018 | - | -$12.43M(-6.1%) | -$40.81M(-43.8%) |
| Mar 2018 | - | -$11.72M(-28.1%) | -$28.39M(-33.1%) |
| Dec 2017 | -$26.55M(-101.0%) | -$9.14M(-21.5%) | -$21.32M(-75.1%) |
| Sep 2017 | - | -$7.53M(-61.9%) | -$12.18M(-161.9%) |
| Mar 2017 | - | -$4.65M | -$4.65M |
| Dec 2016 | -$13.21M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual EBIT year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly EBIT year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM EBIT year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual earnings before interest & taxes?
The current annual EBIT of XERS is -$26.62M
What is the all-time high annual EBIT for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual earnings before interest & taxes is -$13.21M
What is Xeris Biopharma Holdings, Inc. annual EBIT year-on-year change?
Over the past year, XERS annual earnings before interest & taxes has changed by +$10.28M (+27.85%)
What is Xeris Biopharma Holdings, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of XERS is $5.43M
What is the all-time high quarterly EBIT for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly earnings before interest & taxes is $5.43M
What is Xeris Biopharma Holdings, Inc. quarterly EBIT year-on-year change?
Over the past year, XERS quarterly earnings before interest & taxes has changed by +$11.72M (+186.30%)
What is Xeris Biopharma Holdings, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of XERS is -$5.17M
What is the all-time high TTM EBIT for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM earnings before interest & taxes is -$4.65M
What is Xeris Biopharma Holdings, Inc. TTM EBIT year-on-year change?
Over the past year, XERS TTM earnings before interest & taxes has changed by +$25.05M (+82.89%)